Galmed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -3,042 | -1,892 | -2,495 |
EBIT | -2,095 | ||
Net Income | -4,818 | -1,892 | -2,495 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,945 | -1,935 | -1,268 |
Cash | 3,985 | 3,314 | 4,964 |
Basic Shares | 6,581 | 5,460 | 3,948 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -83 | -31 | -35 | |
EBITDA | -10,309 | -7,419 | -6,870 | -17,616 |
EBIT | -7,502 | -6,901 | -17,651 | |
Net Income | -10,309 | -7,517 | -6,912 | -17,866 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,315 | -5,880 | -6,137 | -18,505 |
Cash | 3,985 | 4,652 | 2,861 | 2,016 |
Basic Shares | 4,311 | 930 | 230 | 1,676 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.62 |
2025-12-31 | -$0.92 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.63 |